Shao Q, Bedi K, Malek IA, Shedden K, et al. STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphoma. Leukemia 2025 Feb 5. doi: 10.1038/s41375-025-02525.
PMID: 39910284